Skip to main content

ESTUDIO FARMACOLOGICO DE LA ACTIVIDAD ANTIINFLAMATORIA DE INHIBIDORES FOSFODIESTERASA 4, EN CELULAS EPITELIALES DE VIA AEREA HUMANA IN VITRO, FRENTE AL HUMO DEL TABACO Y /O INFECCIONES POR VIRUS

SAF2008-03113

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2008
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Proyectos de Investigación
Beneficiary centre FUNDACION HOSPITAL GENERAL UNIVERSITARIO (COMUNIDAD DE VALENCIA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences

  • Milara, J
  • Ortiz, JL
  • Juan, G
  • Guijarro, R
  • Martorell, M
  • Morcillo, EJ
  • Cortijo, J
  • Almudéver-Folch, Patricia|||0000-0003-3138-0862
[EN] Background and purpose: Pulmonary arteries from smokers and chronic obstructive pulmonary disease patients show abnormal endothelium-dependent vascular reactivity. We studied the effect of cigarette smoke extract (CSE) on endothelin receptor B (ET(B) ) expression in human pulmonary artery endothelial cells (HPAECs) and its role in endothelial dysfunction. Experimental approach: ET(B) receptor expression was measured by real time RT-PCR, Western blot and immunofluorescence. Cell contraction, intracellular Ca(2+) , F/G-actin, RhoA activity, myosin light chain phosphorylation, ET, NO, thromboxane (Tx)A(2) and reactive oxygen species (ROS) were measured by traction microscopy, fluorescence microscopy, phalloidin fluorescence, colorimetric assay, Western blot, elisa and DCFDA fluorescence respectively. Key results: Cigarette smoke extract dose-dependently increased ET(B) receptor expression in HPAECs after 24h incubation. CSE-induced ET(B) expression was attenuated by bosentan, the ET(B) receptor antagonist BQ788, the Rho kinase antagonist Y27632 and the antioxidant N-acetylcysteine. A monoclonal antibody to ET-1 prevented CSE-induced ET(B) receptor overexpression. Twenty-four hour exposure to ET-1 dose-dependently increased ET(B) receptor expression, mimicking the effect of CSE. CSE-induced ET(B) receptor overexpression caused greater cell contraction; increased intracellular Ca(2+) ; increased F/G-actin and RhoA activity; increased myosin light chain phosphorylation; augmented TxA(2) and ROS production; and decreased NO after acute ET-1 (10nM). These effects were attenuated by bosentan, BQ788, Y27632 and N-acetylcysteine. Conclusions and implication: Cigarette smoke extract induced ET(B) receptor overexpression by a feed forward mechanism mediated partly by ET release, promoting HPAEC dysfunction and attenuated by ET(B) receptor blockade, Rho kinase and ROS inhibition. These results provide support for the use of bosentan in CS-related endothelial dysfunction., This work was supported by grants SAF2008-03113 (JC), SAF2009-08913 (EJM), CIBERES (CB06/06/0027) from Ministry of Science and Innovation and Health Institute 'Carlos III' of Spanish Government, and research grants (Prometeo/2008/045) from Regional Government ('Generalitat Valenciana'). This work was partly supported by Actelion Pharmaceuticals Ltd, Switzerland who provided bosentan.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophages

  • Milara, J.
  • Navarro, A.
  • Lluch, J.
  • Morcillo, E. J.
  • Cortijo, J.
  • Almudéver-Folch, Patricia|||0000-0003-3138-0862
[EN] Background Oxidative stress is present in airway diseases such as severe asthma or Chronic Obstructive Pulmonary Disease and contributes to the low response to glucocorticoids through the down-regulation of histone deacetylase (HDAC) activity. Objective To study the effects of the phosphodiesterase (PDE)-3 and 4 inhibitors and their combination vs. glucocorticoids in a model of lipopolysaccharide (LPS)-induced cytokine release in alveolar macrophages under oxidative stress conditions. Methods Differentiated U937 or human alveolar macrophages were stimulated with H2O2 (10¿1000¿¿m) or cigarette smoke extract (CSE, 0¿15%) for 4¿h before LPS (0.5¿¿g/mL, 24¿h) addition. In other experiments, cells were pre-treated with dexamethasone or budesonide (10¿9¿10¿6¿m), with the PDE4 inhibitor rolipram (10¿9¿10¿5¿m), PDE3 inhibitor motapizone (10¿¿m), 3¿,5¿-cyclic monophosphate enhancer PGE2 (10¿nm), or with the combination of rolipram (10¿6¿m)+PGE2 (10¿nm)+motapizone (10¿¿m) 15¿min before oxidants. IL-8 and TNF-¿ were measured by ELISA and HDAC activity by a colorimetric assay. Results Budesonide and dexamethasone produced a concentration-dependent inhibition of the LPS-induced IL-8 and TNF-¿ secretion with an Emax about 90% of inhibition, which was reduced by approximately 30% in the presence of H2O2 or CSE. Pre-treatment with rolipram, motapizone or PGE2 only reached about 20% of inhibition but was not affected by oxidative stress. In contrast, PDE4/PDE3 combination in presence of PGE2 effectively inhibited the LPS-induced cytokine secretion by about 90% and was not affected by oxidative stress. Combined PDE4 and PDE3 inhibition reversed glucocorticoid resistance under oxidative stress conditions. HDAC activity was reduced in the presence of oxidative stress, and in contrast to glucocorticoids, pre-treatment with PDE4/PDE3 combination was able to prevent HDAC inactivity. Conclusions & Clinical Relevance This study shows that the combination of the PDE3/PDE4 inhibitors prevents alveolar macrophage activation in those situations of glucocorticoid resistance, which may be of potential interest to develop new effective anti-inflammatory drugs in airway diseases., This work was supported by grants SAF2008-03113 (JC), SAF2009-08913 (EJM), and CIBERES (CB06/06/0027) from the Ministry of Science and Innovation and Health Institute 'Carlos III' of Spanish Government, and research grants (Prometeo/2008/045 and Emerging Groups GE-029/10) from the Regional Government ('Generalitat Valenciana').
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Study of the Effect of Proinflammatory Cytokines on the Epithelial Cells of Smokers, With or Without COPD, Estudio del efecto de citocinas proinflamatorias en las células epiteliales de pacientes fumadores con o sin EPOC

  • De Diego Damiá, Alfredo
  • Cortijo Gimeno, Julio
  • Selma Ferrer, María José
  • León Fábregas, Montserrat
  • Milara Payá, Javier
  • Almudéver-Folch, Patricia|||0000-0003-3138-0862
[EN] Cigarette smoke is the main cause of inflammation in COPD. The mechanisms that differentiate smokers who develop COPD are diverse. In this study, we analyzed the presence of cytokines in the respiratory secretions of smokers with or without COPD and the secretory properties of the differentiated bronchial epithelium obtained from the individuals themselves after exposure to tobacco smoke. Material and methods: Twenty-seven smokers were studied, 12 of whom had COPD that had not been previously treated with steroids. In 11, samples were obtained by means of induced sputum, and the remaining samples were collected from bronchial aspiration after bronchoscopy. Concentrations of IL-8, IL-13 and TNF in the supernatant were determined. The results obtained were compared between individuals with and without COPD, and we studied their relationship with the severity of COPD as expressed by the degree of obstruction, dyspnea, presence of hypersecretion and intensity of smoking. Bronchial epithelial cell cultures were obtained by air-liquid interface in 4 smokers. The samples were exposed to increasing concentrations of cigarette smoke (5-20%) and the epithelial mRNA expressions of MUC5AC, IL8 and TNF were determined. COPD patients had significantly higher values of IL-8 than healthy smokers (41 [22] vs. 21 [12] pM). The values of IL-8 correlated significantly with the severity of the obstruction (r = 0.6; p < 0.05), dyspnea (r = 0.45; p < 0.05) and the presence of hypersecretion. There was no relationship between cytokines and the intensity or duration of the tobacco habit. Cigarette smoke produced a dose-dependent increase in the expression of RNAm for Muc5AC, IL8 and TNF. There are differences in cytokine production (fundamentally IL8) between smokers and smokers with COPD which could be explained by the direct action of cigarette smoke on epithelial cells., [ES] El humo de tabaco es la principal causa de la inflamación en la EPOC. Los mecanismos que diferencian a los fumadores que desarrollan EPOC son diversos. En este estudio analizamos la diferente presencia de citocinas en secreciones respiratorias de pacientes fumadores con o sin EPOC y las propiedades secretoras del epitelio bronquial diferenciado, obtenido de los propios individuos tras su exposición al humo de tabaco. Material y métodos: Se estudió a 27 pacientes fumadores, 12 de ellos con EPOC no tratados previamente con esteroides. En 11 se obtuvo la muestra mediante esputo inducido y el resto procedía del aspirado bronquial tras fibrobroncoscopia. Se determinaron las concentraciones de IL8, IL13 y TNF en el sobrenadante. Se compararon los resultados obtenidos entre individuos con o sin EPOC y se investigó su relación con la gravedad de la EPOC expresada según el grado de obstrucción, disnea, presencia de hipersecreción e intensidad del tabaquismo. Se obtuvieron cultivos de células diferenciadas epiteliales bronquiales, mediante interfase aire-líquido en 4 individuos fumadores. Las muestras fueron expuestas a concentraciones crecientes de humo de tabaco (5-20%) y se determinó la expresión epitelial de ARNm de Muc5AC, IL8 y TNF. Los pacientes con EPOC tenían valores significativamente más altos de IL8 que los fumadores sanos (41 [22] vs. 21 [12] pM). Los valores de IL8 se correlacionaron de forma significativa con la gravedad de la obstrucción (r = 0,6; p < 0,05), disnea (r = 0,45; p < 0,05) y la presencia de hipersecreción. No había relación entre las citocinas y la intensidad o duración del hábito tabáquico. El humo de tabaco produjo un incremento dependiente de la dosis en la expresión de ARNm para Muc5AC, IL8 y TNF. Existen diferencias en la producción de citocinas, fundamentalmente IL8, entre individuos fumadores sanos o con EPOC que podrían ser justificadas por la acción directa del humo de tabaco sobre las células epiteliales., Subvencionado con las becas / Funded by the following grants: SVN 2004, SEPAR 2005, SAF2008-03113, CIBERES (CB06/06/0027).